Invivo ultrasound visualization of non-occlusive blood clots with thrombin-sensitive contrast agents

Biomaterials

Volumn 34, Issue 37, 2013, Pages 9559-9565

  Nakatsuka, Matthew A ^a   Barback, Christopher V ^b   Fitch, Kirsten R ^c   Farwell, Alexander R ^c   Esener, Sadik C ^a   Mattrey, Robert F ^b   Cha, Jennifer N ^a,c   Goodwin, Andrew P ^c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University of Colorado at Boulder   (United States)

Author keywords

Clotting; DNA; Invitro test; Invivo test; Thrombosis

Indexed keywords

CHEMICAL ENVIRONMENT; CLOTTING; DEEP VENOUS THROMBOSIS; IN-VITRO TESTS; IN-VIVO TESTS; THROMBOSIS; ULTRASOUND CONTRAST; ULTRASOUND CONTRAST AGENT;

BLOOD; CROSSLINKING; DISEASES; DNA; SHEAR FLOW; ULTRASONIC APPLICATIONS; ULTRASONICS;

ENZYMES;

APTAMER; BIOLOGICAL MARKER; ECHO CONTRAST MEDIUM; POLY(ETHYLENE GLYCOL) STABILIZED THROMBIN ACTIVATED MICROBUBBLE CONTRAST AGENT; THROMBIN; UNCLASSIFIED DRUG; CONTRAST MEDIUM; DIAGNOSTIC AGENT; DNA; THROMBIN APTAMER;

ACOUSTIC IMPEDANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY RESPONSE; BLOOD CLOT; BLOOD CLOTTING; CAVA VEIN; CIRCULATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DNA CROSS LINKING; ECHOGRAPHY; FEMALE; INFERIOR CAVA VEIN; MICROBUBBLE; MOLECULAR IMAGING; NON OCCLUSIVE BLOOD CLOT; NONHUMAN; PRIORITY JOURNAL; RABBIT; SENSITIVITY AND SPECIFICITY; SHEAR STRESS; ANIMAL; CHEMISTRY; CLOTTING; IN VITRO TEST; IN VIVO TEST; METABOLISM; NUCLEOTIDE SEQUENCE; THROMBOSIS; VEIN THROMBOSIS; DIAGNOSTIC USE;

ORYCTOLAGUS CUNICULUS;

CLOTTING; DNA; IN VITRO TEST; IN VIVO TEST; THROMBOSIS;

ANIMALS; APTAMERS, NUCLEOTIDE; BASE SEQUENCE; BLOOD COAGULATION; CONTRAST MEDIA; FEMALE; MICROBUBBLES; RABBITS; THROMBIN; VENOUS THROMBOSIS;

EID: 84884816269     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.08.040     Document Type: Article

References (30)

1. Schutt E.G., Klein D.H., Mattrey R.M., Riess J.G. Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: the key role of perfluorochemicals. Angew Chem Int Ed Engl 2003, 42:3218-3235.
2. Ferrara K.W., Borden M.A., Zhang H. Lipid-shelled vehicles: engineering for ultrasound molecular imaging and drug delivery. Acc Chem Res 2009, 42:881-892.
3. Sboros V. Response of contrast agents to ultrasound. Adv Drug Deliv Rev 2008, 60:1117-1136.
4. Pancholi K.P., Farook U., Moaleji R., Stride E., Edirisinghe M.J. Novel methods for preparing phospholipid coated microbubbles. Eur Biophys J 2008, 37:515-520.
5. Lindner J.R., Dayton P.A., Coggins M.P., Ley K., Song J., Ferrara K., et al. Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. Circulation 2000, 102:531-538.
6. Kamaev P.P., Hutcheson J.D., Wilson M.L., Prausnitz M.R. Quantification of optison bubble size and lifetime during sonication dominant role of secondary cavitation bubbles causing acoustic bioeffects. JAcoust Soc Am 2004, 115:1818-1825.
7. Cui W., Bei J., Wang S., Zhi G., Zhao Y., Zhou X., et al. Preparation and evaluation of poly(L-lactide-co-glycolide) (PLGA) microbubbles as a contrast agent for myocardial contrast echocardiography. JBiomed Mater Res Part B Appl Biomater 2005, 73:171-178.
8. Borden M.A., Pu G., Runner G.J., Longo M.L. Surface phase behavior and microstructure of lipid/PEG-emulsifier monolayer-coated microbubbles. Colloids Surf B Biointerfaces 2004, 35:209-223.
9. Borden M.A., Longo M.L. Dissolution behavior of lipid monolayer-coated, air-filled microbubbles: effect of lipid hydrophobic chain length. Langmuir 2002, 18:9225-9233.
10. Lindner J.R. Molecular imaging of cardiovascular disease with contrast-enhanced ultrasonography. Nat Rev Cardiol 2009, 6:475-481.
11. Anderson C.R., Hu X., Zhang H., Tlaxca J., Decleves A.E., Houghtaling R., et al. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent. Invest Radiol 2011, 46:215-224.
12. Willmann J.K., Cheng Z., Davis C., Lutz A.M., Schipper M.L., Nielsen C.H., et al. Targeted microbubbles for imaging tumor angiogenesis: assessment of whole-body biodistribution with dynamic micro-PET in mice. Radiology 2008, 249:212-219.
13. Heng Tan C., Bedi D., Vikram R. Sonography of thrombosis of the deep veins of the extremities: clinical perspectives and imaging review. JClin Ultrasound 2012, 40:31-43.
14. Coley B.D., Trambert M.A., Mattrey R.F. Perfluorocarbon-enhanced sonography: value in detecting acute venous thrombosis in rabbits. AJR Am J Roentgenol 1994, 163:961-964.
15. Maul T.M., Dudgeon D.D., Beste M.T., Hammer D.A., Lazo J.S., Villanueva F.S., et al. Optimization of ultrasound contrast agents with computational models to improve selection of ligands and binding strength. Biotechnol Bioeng 2010, 107:854-864.
16. Wang C.H., Kang S.T., Lee Y.H., Luo Y.L., Huang Y.F., Yeh C.K. Aptamer-conjugated and drug-loaded acoustic droplets for ultrasound theranosis. Biomaterials 2012, 33:1939-1947.
17. Klibanov A.L. Ligand-carrying gas-filled microbubbles: ultrasound contrast agents for targeted molecular imaging. Bioconjug Chem 2005, 16:9-17.
18. Simberg D., Mattrey R. Targeting of perfluorocarbon microbubbles to selective populations of circulating blood cells. JDrug Target 2009, 17:392-398.
19. Shi G., Cui W., Benchimol M., Liu Y.T., Mattrey R.F., Mukthavaram R., et al. Isolation of rare tumor cells from blood cells with buoyant immuno-microbubbles. PLoS ONE 2013, 8:e58017.
20. Takalkar A.M., Klibanov A.L., Rychak J.J., Lindner J.R., Ley K. Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flow. JControl Release 2004, 96:473-482.
21. Nakatsuka M.A., Hsu M.J., Esener S.C., Cha J.N., Goodwin A.P. DNA-coated microbubbles with biochemically tunable ultrasound contrast activity. Adv Mater 2011, 23:4908-4912.
22. Nakatsuka M.A., Mattrey R.F., Esener S.C., Cha J.N., Goodwin A.P. Aptamer-crosslinked microbubbles: smart contrast agents for thrombin-activated ultrasound imaging. Adv Mater 2012, 24:6010-6016.
23. Nakatsuka M.A., Lee J.H., Nakayama E., Hung A.M., Hsu M.J., Mattrey R.F., et al. Facile one-pot synthesis of polymer-phospholipid composite microbubbles with enhanced drug loading capacity for ultrasound-triggered therapy. Soft Matter 2011, 2011:1656-1659.
24. Nutiu R., Li Y. Structure-switching signaling aptamers. JAm Chem Soc 2003, 125:4771-4778.
25. Borden M.A., Zhang H., Gillies R.J., Dayton P.A., Ferrara K.W. Astimulus-responsive contrast agent for ultrasound molecular imaging. Biomaterials 2008, 29:597-606.
26. Hosny N.A., Mohamedi G., Rademeyer P., Owen J., Wu Y., Tang M.X., et al. Mapping microbubble viscosity using fluorescence lifetime imaging of molecular rotors. Proc Natl Acad Sci U S A 2013.
27. Wessler S. Studies in intravascular coagulation. I. Coagulation changes in isolated venous segments. JClin Invest 1952, 31:1011-1014.
28. Miller D.L. Frequency relationships for ultrasonic activation of free microbubbles, encapsulated microbubbles, and gas-filled micropores. JAcoust Soc Am 1998, 104:2498-2505.
29. Postema M., Bouakaz A., Versluis M., de Jong N. Ultrasound-induced gas release from contrast agent microbubbles. IEEE Trans Ultrason Ferroelectr Freq Control 2005, 52:1035-1041.
30. Bock L.C., Griffin L.C., Latham J.A., Vermaas E.H., Toole J.J. Selection of single-stranded-DNA molecules that bind and inhibit human thrombin. Nature 1992, 355:564-566.